viimane versioon :
19/11/2024
antibiootikum   Sulfadiazine  
suukaudne lahus
Stabiilsust ravimpreparaadid Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Viited pdf
   keemiline struktuur  

suukaudne lahus
Viited   suukaudne lahus   Viited : Sulfadiazine  
tüüp avaldamine
2795 ajaleht Pathmanathan U, Halgrain D, Chiadmi F, Schlmatter J, Vermerie N.
Stability of sulfadiazine oral liquids prepared from tablets and powder.
J Pharm Pharm Sci 2004 ; 7, 1: 84-87.
3819 ajaleht Ferreiraa A.O, Poloninia H.C, Silva S.L, Patricio F.B, Brand?oa M.A.F, Raposoa N.R.B.
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions.
J Pharm Biomed Anal 2015 ; 118: 105-112.
4030 ajaleht Graves R, Phan K, Bostanian L, Mandal T, Pramar Y.
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt.
Int J Pharm Compound 2017 ; 21, 5 : 430-435
4789 ajaleht Micheline Silva Dias, Amanda Maccangnan Zamberlan, Rebeca Lino Lourenço, Emanuele Saul Saraiva, Julya Sarmento Neis et al.
Stability of sulfadiazine sugar-free oral suspensions for the treatment of congenital toxoplasmosis.
Braz J Pharm Sci 2023 ; 59: e23359.

  Mentions Légales